| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to compositions of an antioxidant composition aimed at the suppression of oxidative stress in type 2 diabetes. The said compositions contain, counted per 1 dose: 50-120 mg of coenzyme Q10, 30-160 mg of dihydroquercetin, and 30-60 mg of A-lipoic acid or 50-100 mg of coenzyme Q10, 50-100 mg of dihydroquercetin, 30-60 mg of A-lipoic acid and 50-100 mg of nicotineamide.EFFECT: compositions possess an antioxidant activity and prevent the development of the fatty tissue dysfunction.2 cl, 1 dwg, 2 tbl, 2 ex |
